Early Infusion Pump "Assurance" Cases Inadequate, CDRH Branch Chief Says

The first attempts by infusion pump manufacturers to develop "assurance" cases to validate product safety in 510(k) submissions have not been particularly successful, according to FDA

More from Archive

More from Medtech Insight